AMY W SCHULMAN

CIK 1438226 · Former Exec. Vice President · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.22M

Companies

14

Total Filings

108

Lifetime Open-Market Net

$64.31M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALNY Director 24,049 $246.11 $5.92M -$5.26M 20 2026-05-22
ELV Director 781 $403.04 $314.8K -$7.5K 3 2026-05-15
GUTS Director 8,550 $0.71 $6.1K $10.0K 3 2025-06-13
CAMP 10%+ Owner 112,193 $3.79 $425.2K $60.00M 1 2024-10-15
SQZ Biotechnologies Co (SQZ) Delisted Director 216,664 $0.43 $94.2K $4.04M 7 2023-06-15
Hudson Executive Investment Corp. II (HCIIW) Delisted Director $0.00 $0 1 2021-04-14
CYCN Director 209 $4.17 $872 $10.02M 4 2020-06-18
IRWD Director 38,242 $4.27 $163.3K $0 7 2019-04-03
IRONWOOD PHARMACEUTICALS INC (IRWDV) Delisted Director 42,298 $0 1 2019-03-19
X4 Pharmaceuticals, Inc (ASNS) Delisted Director $0.08 $0 3 2018-06-07
BUFF Director 0 $53.59 $0 $0 3 2018-04-24
DNIB UNWIND, INC. (BIND) Delisted Director $0 2 2015-06-10
PFE Former Exec. Vice President 280,380 $28.55 $8.00M -$4.61M 50 2014-01-02
ZTS Director 5,000 $77.25 $386.2K $130.0K 1 2013-02-08

Recent Filings · Page 5 of 11

108 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-06-22 ALNY Grant (A) $0 EDGAR
2018-06-19 IRWD Grant (A) +126 $0 EDGAR
2018-06-07 X4 Pharmaceuticals, Inc (ASNS) Delisted Grant (A) $0 EDGAR
2018-06-04 IRWD Grant (A) +16,223 $0 EDGAR
2018-04-24 BUFF Disp (D) −14,819 $0 EDGAR
2018-03-05 X4 Pharmaceuticals, Inc (ASNS) Delisted Grant (A) $0 EDGAR
2017-12-01 X4 Pharmaceuticals, Inc (ASNS) Delisted Grant (A) $0 EDGAR
2017-06-06 ALNY Grant (A) $0 EDGAR
2017-06-02 IRWD Grant (A) +15,625 $0 EDGAR
2017-04-04 BUFF Grant (A) +3,695 $0 EDGAR
Showing 4150 of 108
Page 5 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.